Dayya David, O'Neill Owen, Habib Nusrat, Moore Joanna, Iyer Kartik, Huedo-Medina Tania B
Division of Undersea and Hyperbaric Medicine, Department of Surgery, Phelps Hospital Northwell Health, Sleepy Hollow, New York, USA.
Department of Surgery, Zucker School of Medicine, Hofstra University/Northwell, Hempstead, NY, USA.
BMJ Surg Interv Health Technol. 2022 May 30;4(1):e000081. doi: 10.1136/bmjsit-2021-000081. eCollection 2022.
Diabetic foot ulceration (DFU) has devastating complications and a lifetime occurrence of 15%-34%. Debridement of DFU is regarded as an intervention that accelerates ulcer healing and may reduce complications including amputations, infections, and poor quality of life (QoL), which have serious public health and clinical implications. A systematic review (SR) of SRs and of randomized controlled trials (RCTs) with meta-analyses (MAs) on debridement of DFU that synthesizes all human experimental evidence is warranted.
Are debridement methods in DFU beneficial over other forms and standard gauze dressings (control condition) in these outcomes?
All SRs/MAs/RCTs comparing debridement methods for DFU with alternative methods of debridement and with control.
Cochrane Wounds Group Specialized Register, Cochrane Central Register of Controlled Trials (Cochrane Library), Ovid MEDLINE, PubMed, EMBASE, EBSCO, CINAHL, and Web of Science.
Adults with type 1/2 diabetes with DFU and any debridement method compared with alternative debridement methods or control.
Amputation rates, wound infections, QoL, proportion of ulcers healed, time to complete healing, ulcer recurrence, and treatment cost.
Data extraction/synthesis by two independent reviewers pooled using a random-effects model with sensitivity analysis.
10 SRs were retrieved and reported qualitatively. Six SRs included MAs. This SR included 30 studies, with 2654 participants, using 19 debridement combinations. The debridement methods were compared with findings pooled into MAs. Meta-regression (MR) did not identify significant predictors/moderators of outcomes.
The studies may have been under-powered. The inclusion/exclusion criteria varied and the increased risk of bias contributed to low-quality evidence.
DISCUSSION/CONCLUSION: Weak evidence exists that debridement methods are superior to other forms of debridement or control in DFU.
Researchers should follow standardized reporting guidelines (Consolidated Standards of Reporting Trials). Clinicians/investigators could use the findings from this SR/MA/MR in guiding patient-individualized decision making and designing future RCTs.
糖尿病足溃疡(DFU)具有严重的并发症,终生发病率为15%-34%。DFU清创术被视为一种可加速溃疡愈合并可能减少包括截肢、感染和生活质量低下等并发症的干预措施,这些并发症具有严重的公共卫生和临床意义。有必要对关于DFU清创术的系统评价(SR)以及带有荟萃分析(MA)的随机对照试验(RCT)进行系统评价,以综合所有人体实验证据。
在这些结果方面,DFU的清创方法是否比其他形式和标准纱布敷料(对照情况)更有益?
所有比较DFU清创方法与其他清创方法及对照的SR/MA/RCT。
Cochrane伤口小组专业注册库、Cochrane对照试验中心注册库(Cochrane图书馆)、Ovid MEDLINE、PubMed、EMBASE、EBSCO、CINAHL和科学网。
患有1型/2型糖尿病并伴有DFU的成年人,将任何清创方法与其他清创方法或对照进行比较。
截肢率、伤口感染、生活质量、溃疡愈合比例、完全愈合时间、溃疡复发和治疗费用。
由两名独立 reviewers 使用随机效应模型合并数据提取/合成,并进行敏感性分析。
检索到10项SR并进行了定性报告。6项SR包括MA。本SR纳入了30项研究,共2654名参与者,使用了19种清创组合。将清创方法与汇总到MA中的结果进行了比较。Meta回归(MR)未确定结局的显著预测因素/调节因素。
这些研究可能样本量不足。纳入/排除标准各不相同,偏倚风险增加导致证据质量较低。
讨论/结论:有微弱证据表明清创方法在DFU方面优于其他形式的清创或对照。
研究人员应遵循标准化报告指南(试验报告统一标准)。临床医生/研究人员可利用本SR/MA/MR的结果指导患者个体化决策并设计未来的RCT。